Home  »  Science   »  Bears Are Back On The Defensive As Kiromic BioPhar...

Bears Are Back On The Defensive As Kiromic BioPharma Inc. (KRBP) swung 33.56%

Kiromic BioPharma Inc. (NASDAQ:KRBP) has seen 3.71 million shares traded in the last trading session. The company, currently valued at $4.95M, closed the last trade at $0.28 per share which meant it gained $0.07 on the day or 33.56% during that session. The KRBP stock price is -350.0% off its 52-week high price of $1.26 and 46.43% above the 52-week low of $0.15. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.29 million shares traded. The 3-month trading volume is 109.39K shares.

Kiromic BioPharma Inc. (NASDAQ:KRBP) trade information

Sporting 33.56% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on Monday, 01/23/23 when the KRBP stock price touched $0.28. Year-to-date, Kiromic BioPharma Inc. shares have moved 53.29%, while the 5-day performance has seen it change 31.78%. Over the past 30 days, the shares of Kiromic BioPharma Inc. (NASDAQ:KRBP) have changed 45.79%. Short interest in the company has seen 0.6 million shares shorted with days to cover at 0.36.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…

Sponsored

Kiromic BioPharma Inc. (KRBP) estimates and forecasts

Figures show that Kiromic BioPharma Inc. shares have underperformed across the wider relevant industry. The company’s shares have lost -22.19% over the past 6 months, with this year growth rate of -58.50%, compared to 4.50% for the industry. Other than that, the company has, however, lowered its growth outlook for the 2023 fiscal year revenue. Growth estimates for the current quarter are -40.00% and 25.00% for the next quarter.

KRBP Dividends

Kiromic BioPharma Inc. is expected to release its next earnings report between March 09 and March 13 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Kiromic BioPharma Inc. (NASDAQ:KRBP)’s Major holders

Insiders own 17.21% of the company shares, while shares held by institutions stand at 6.81% with a share float percentage of 8.22%. Investors are also buoyed by the number of investors in a company, with Kiromic BioPharma Inc. having a total of 18 institutions that hold shares in the company. The top two institutional holders are Zeke Capital Advisors, Llc with over 0.11 million shares worth more than $45485.0. As of Jun 29, 2022, Zeke Capital Advisors, Llc held 0.68% of shares outstanding.

The other major institutional holder is HRT Financial LP, with the holding of over 78854.0 shares as of Jun 29, 2022. The firm’s total holdings are worth over $33520.0 and represent 0.50% of shares outstanding.

Also the top two Mutual Funds that are holding company’s shares are Fidelity NASDAQ Composite Index Fund and Fidelity Extended Market Index Fund. As of Jun 29, 2022, the former fund manager holds about 0.23% shares in the company for having 36662.0 shares of worth $15585.0 while later fund manager owns 4300.0 shares of worth $1827.0 as of Jun 29, 2022, which makes it owner of about 0.03% of company’s outstanding stock.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts